1. Eli Lilly reports a reduced rate of hospitalization for coronavirus patients using its antibody treatment  CNBC
  2. Lilly's Covid-19 antibody helps patients rid their systems of virus sooner  STAT
  3. Shares of Lilly gain as it discloses promising interim findings for COVID-19 antibody treatment  MarketWatch
  4. Eli Lilly reports results from Covid-19 phase 2 antibody drug trial  CNBC Television
  5. View Full coverage on Google News

Lilly, which is developing the drug with the biotechnology firm Abcellera, tested three doses of its antibody against placeboLilly, which is developing the drug with the biotechnology firm Abcellera, tested three doses of its antibody against placebo

Lilly’s Covid-19 antibody helps patients rid their systems of virus sooner

Shares of Eli Lilly & Co. undefined gained 2.6% in premarket trading on Wednesday after the drug maker said interim data from a mid-stage clinical trial...Shares of Eli Lilly & Co. undefined gained 2.6% in premarket trading on Wednesday after the drug maker said interim data from a mid-stage clinical trial...

Shares of Lilly gain as it discloses promising interim findings for COVID-19 antibody treatment - MarketWatch